is semaglutide available in europe Novo Nordisk gets green light for higher-dose Wegovy The UK has become the

Reddit backs this up

Pfizer's danuglipron, once considered the primary competitor, was discontinued in April 2025 after a case of potential drug-induced liver injury in a dose-optimization study, following the earlier termination of lotiglipron in 2023 for similar hepatic concerns

However, to avoid possible adverse effects, it is recommended to start at 0.25 mg, which should be gradually increased over a period of 16 weeks

It neutralises free radicals through reduction reactions, donating electrons to unstable molecules and preventing oxidative damage to proteins, lipids, and DNA

Clean presentation, responsive support and smooth EU delivery

These soft tissue injuries represent training time lost and competitive opportunities missed